Article
RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies.
Arthritis & rheumatology (Hoboken, N.J.) - 1 May 2014
Kung Tabitha N, Dennis Jessica, Ma Yiqing, Xie Gang, Bykerk Vivian, Pope Janet, Thorne Carter, Keystone Edward, Siminovitch Katherine A, Gagnon France
Abstract excerpt
OBJECTIVE: Associations have been reported between candidate genes and the response to methotrexate (MTX) in rheumatoid arthritis (RA) patients, but most of the studies have been small and have yielded conflicting results. This study was undertaken to provide a systematic review of all genetic variant associations with MTX efficacy and toxicity, and to conduct a meta-analysis evaluating the most commonly studied...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
